Studies on crystal-induced chemotactic factor. I. Requirement for protein synthesis and neutral protease activity.
D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D002403:Cathepsins / Q000378:metabolism; D002458:Cell Fractionation; D002633:Chemotaxis / Q000187:drug effects; D003078:Colchicine / Q000494:pharmacology; D003080:Cold Temperature; D003460:Crystallization; D003609:Dactinomycin / Q000494:pharmacology; D006358:Hot Temperature; D006863:Hydrogen-Ion Concentration; D007962:Leukocytes / Q000378:metabolism; D008247:Lysosomes / Q000201:enzymology / Q000378:metabolism; D010447:Peptide Hydrolases / Q000378:metabolism*; D010587:Phagocytosis / Q000187:drug effects; D011480:Protease Inhibitors; D014176:Protein Biosynthesis; D011817:Rabbits; D014361:Trypsin Inhibitors / Q000494:pharmacology; D014527:Uric Acid
D000614:Aminocaproates; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D003609:Dactinomycin; D014527:Uric Acid; D007611:Aprotinin; D002403:Cathepsins; D010447:Peptide Hydrolases; D003078:Colchicine